37 min
Insights into innovation investment from venture capitalist Dr Chris Smith Med Tech Talks Podcast
-
- Life Sciences
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Dr Chris Smith, a partner at Brandon Capital - Australasia's leading life science venture capital firm.
Chris has extensive experience in the global biotech industry. With a PhD in immunology and an MBA specialising in innovation and entrepreneurship from the University of Cambridge; he has also previously been a business development manager with CSL; and is currently a Director of Aravax, Denteric, Ena Respiratory, MycRx, Q-Sera and Axelia Oncology, just to name a few.
In this episode, you will hear more about:
Tips for pitching to investors and building a relationship with venture capital firmsDemystifying the role of a VC in research and developmentBrandon Capital’s incubator approach to risk and investing in early-stage innovations.
Learn about Dr Chris Smith
Visit the Brandon Capital website
Updated version 05/08/22
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Dr Chris Smith, a partner at Brandon Capital - Australasia's leading life science venture capital firm.
Chris has extensive experience in the global biotech industry. With a PhD in immunology and an MBA specialising in innovation and entrepreneurship from the University of Cambridge; he has also previously been a business development manager with CSL; and is currently a Director of Aravax, Denteric, Ena Respiratory, MycRx, Q-Sera and Axelia Oncology, just to name a few.
In this episode, you will hear more about:
Tips for pitching to investors and building a relationship with venture capital firmsDemystifying the role of a VC in research and developmentBrandon Capital’s incubator approach to risk and investing in early-stage innovations.
Learn about Dr Chris Smith
Visit the Brandon Capital website
Updated version 05/08/22
37 min